Alemtuzumab trials for Sickle cell disease

All Alemtuzumab trials · All Sickle cell disease trials

Phase breakdown

Recruiting trials studying Alemtuzumab for Sickle cell disease

• Allo HSCT for High Risk Hemoglobinopathies
  NCT06872333 · Phase: Phase 2 · Ages: Up to 55 Years · Sex: All (male and female) · 1 location
• Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease
  NCT07616154 · Phase: Phase 2 · Ages: Up to 22 Years · Sex: All (male and female) · 1 location
• Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor
  NCT03214354 · Phase: Phase 2 · Ages: 1 Year to 19 Years · Sex: All (male and female) · 1 location
• Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors
  NCT07599176 · Phase: Phase 1, Phase 2 · Ages: 4 Years to 65 Years · Sex: All (male and female) · 1 location
• Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
  NCT01962415 · Phase: Phase 2 · Ages: 2 Months to 55 Years · Sex: All (male and female) · 2 locations
• Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody
  NCT06358638 · Phase: Phase 2 · Ages: 2 Years to 25 Years · Sex: All (male and female) · 1 location
• T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
  NCT03653338 · Phase: Phase 1, Phase 2 · Ages: 5 Years to 40 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Alemtuzumab for Sickle cell disease?

7 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.